Vilnius-based Biomatter raises €16.2 million to make AI-designed custom enzymes not found in nature
Biomatter, a Vilnius-based custom enzyme design company that delivers catalysts to solve real-world problems across industries, today announced the closing of an oversubscribed €16.2 million ($18 million) Series A financing. The round was led by Astanor, …